Skip to main content

Swayampakula Ramakanth (RK)

Analyst

H.C. Wainwright

Equibles does not estimate personal net worth.

About Swayampakula Ramakanth (RK)

Swayampakula Ramakanth (RK) is recorded as Analyst at H.C. Wainwright. Swayampakula Ramakanth (RK) has spoken on 5 earnings calls across 5 companies, most recently for Corcept Therapeutics Inc on July 29, 2026. Those appearances were for Corcept Therapeutics Inc (CORT), Ocugen, Inc. (OCGN), Evotec SE (EVO), Innate Pharma SA (IPHA) and Lifeward Ltd. (LFWD). The companies whose calls Swayampakula Ramakanth (RK) spoke on are classified in the Healthcare sector.

Swayampakula Ramakanth (RK) on recent calls

“I have just a couple of questions, one on LeFiori and one on Coraline. and literally did approximately $48 million in the first quarter with more than 1,300 patients started, as you stated.”
Analyst — H.C. Wainwright, Corcept Therapeutics Q2 2026 Earnings Conference Call ·
“A lot of my questions have been answered, but I have a couple of them.”
Analyst — H.C. Wainwright, Ocugen, Inc. Q1 FY2026 Earnings Call ·
“One is on the Horizon implementation, with an expectation of 800 positions being cut and consolidation to 10 sites. Just trying to understand what could be the risk of customer disruption, especially from the talent loss?”
Analyst — H.C. Wainwright, Evotec SE Q4 FY2025 Earnings Call ·
“You know, just to get started with IPH 4502, you know, you are, you know, reporting some preliminary anti, you know, tumor activity in the ongoing trial.”
Analyst — H.C. Wainwright, Innate Pharma SA Q1 FY2026 Earnings Call ·
“This is R.K. from H.F.N. Good morning, Mark and Elmob. A broad, high-level question, you know, similar to what Yael was just asking. I think about two or almost three years ago now, the previous management brought in Alter to kind of expand on their, you know, within the medtech mobility space.”
Analyst — H.C. Wainwright, Lifeward Ltd. Q4 FY2025 Earnings Call ·

Affiliation history

  • H.C. Wainwright

    Analyst

    Source not stated

    Current

Company network

Recent activity